Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Stretching may help reduce painful orthopedic issues among echo and interventional lab staff

Orthopedic issues are the biggest work-related injury in cardiology, but this low cost intervention may help.

Video interview with Matthew Reynolds, MD, who shares data on largest wearable ambulatory cardiac monitoring studies to date from the EXCALIBER and CAMELOT trials at HRS 2024. #HRS #HRS2024 #Remotemonitoring

First large-scale studies of wearable ambulatory cardiac monitoring shed light on usage 

Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.

More than 5,600 cardiac ultrasound measurements are now automated using artificial intelligence in the new Siemens Acuson Origin echocardiography system. It is the first echo system to use AI to help automate and anticipate next actions to greatly speed workfor and increase reproducibility between sonographers. Photo by Dave Fornell at ESC 2023

Cardiovascular ultrasound innovations being showcased at ASE 2024 meeting

New cardiac ultrasound advances, from AI to completely study workflow, new 3D/4D catheters, virtual reality simulators, to robot-assisted ultrasound, will be presented on the expo floor of ASE 2024 this weekend in Portland.

The central illustration from a study that shows the impact of ECG AI algorithm study case and control selection to train artificial intelligence to better screening patients for cardiac amyloidosis. Image courtesy of JACC Advances.

Using ECG AI to find the cardiac amyloidosis needles in the haystack

Early detection of cardiac amyloidosis is leads to the best outcomes, but it is often missed until later stages. AI is being developed to help detect these patients earlier using ECG and echo.

There has been a growing shortage of cardiologists the past several years, but this has accelerated due to burnout from the pandemic, falling reimbursements and increasing administrative burdens. This prompted a joint session on this topic with the ACC and the Heart Rhythm Society at HRS 2024, with ACC President Cathie Biga, MSN, FACC, president and CEO of Cardiovascular Management of Illinois, former ACC president Ed Fry, MD, chair of the Ascension National Cardiovascular Service Line, and EP Parin Patel.

Addressing staffing shortages in cardiology

ACC President Cathie Biga, MSN, RN, Edward Fry, MD, and electrophysiologist Parin Patel, MD, discuss the growing cardiologist shortage.

healthcare value value-based care money dollar

Medical device company raises $104M to fund PFA research

Early research suggests Kardium's PFA system could give cardiologists a new tool for the fight against atrial fibrillation. The company plans to study its technology even more with this latest round of funding. 

Stuart Connolly, MD, a veteran cardiologist known for his groundbreaking work in the field of electrophysiology, died June 2 after a long battle with neuroendocrine cancer.

Cardiologist Stuart Connolly remembered as a ‘generational thinker,’ electrophysiology pioneer

Connolly spent 40 years at McMaster University as a professor and researcher, founding the school’s cardiac arrhythmia service line and serving as its cardiology chair. He remained active in electrophysiology research until the end of his life.

Paul Zei, MD, director of the comprehensive atrial fibrillation program at Brigham and Women’s Hospital, explained key findings from the late-breaking REAL-AF Registry at the Heart Rhythm Society (HRS) 2024 conference. This registry study evaluated the short- and long-term outcomes of radiofrequency ablation (RF) in treating both paroxysmal atrial fibrillation (PAF) and persistent atrial fibrillation (PsAF), revealing significant advancements in procedural techniques and patient safety. #EPeeps #HRS2024

Interest growing in fluoroscopy-free workflows during RF ablation

Paul Zei, MD, discusses late-breaking data from the REAL-AF Registry, which looked at the short- and long-term outcomes of radiofrequency ablation in paroxysmal and persistent atrial fibrillation.

Displaying 185 - 192 of 1685
Design by Adaptive Theme